$DISH is today lurking almost unchanged after the better than expected Q3 EPS $0.86 vs $0.66 estimated. This is a typical Wall Street trick like that for $GILD in order to pressure the market to sell low to crocodiles before its soaring back to the fair value level $35+ for $DISH and $70+ for $GILD. As such, fellow guys, please hold tight $DISH and $GILD till they rebound astonishingly!!!! Be patient, just in a couple of weeks, they have to go back to their fair market value !!!
jeanfrancois.tsoon
Posts
-
-
$DISH earnings Q3 2020
November 6, 2020
ENGLEWOOD, Colo., Nov. 6, 2020 /PRNewswire/ -- DISH Network Corporation (NASDAQ: DISH) reported revenue totaling $4.53 billion for the quarter ending September 30, 2020, compared to $3.17 billion for the corresponding period in 2019.Net income attributable to DISH Network totaled $505 million for the third quarter 2020, compared to $353 million from the year-ago quarter. Diluted earnings per share were $0.86 for the third quarter, compared to $0.66 per share during the same period in 2019.
-
$GILD management wants to be politically correct: if they forecast the hospitalization goes up that’ll lead to their revenue up, $GILD will invite the criticism that they anticipate to make money out of the life loss and suffer of Covid-19 patients worldwide! So, the BIG BULL is on the way as the COVID-19 resurgence is taking place and won’t end in at least a year!
-
$GILD price is rigged as evidenced by the after-hours price drop disregard the fact Q3 EPS $2.11 beats $1.83 estimate!
-
Q3 EPS $2.11 versus $1.83 median estimate! $GILD will jump to $70s tomorrow!!!!!
-
$ERJ Right Size is the very key for post-pandemic air travel! Embraer E2 single-aisle jet is the solution for airline industry to reinvent itself!!
-
$EADSY Airbus continues up +2.41% from last Friday’s jump +3.988% in Paris Exchange when $CAC40 is down -0.39% on Monday!
The same story is going to happy for $ERJ!Embraer will be continuing UP of last Friday’s rebound +3.988% as this 3rd aircraft giant is way too much undervalued!!!!! Let’s not forget the E2 series jets of $ERJ is seeing the rising demand as the pandemic has dramatically changed air travel industry—smaller regional jets like $ERJ E195-E2 and Airbus A220 (former Bombardier $BBD.B C Series Regional Jets) become hot as result of shrinking travelers volume and increasing more direct point-to-point flights!
-
$ERJ AS of September 30, the Embraer order backlog totaled USD 15.1 bln. The firm delivered a total of 28 jets in the third quarter of 2020, of which seven were commercial aircraft and 21 were executive jets (19 light and 2 large).
-
$ERJ Samba Bull IS ON THE WAY!!! Boom next Monday!!!!!
-
Isn’t current condition much better than May? It will jump to $8 tomorrow!!! Don’t sell guys!
-
#ERJ Embraer is close to joint venture deal with India or China which will inject plenty of capital soon... HOLD!!!
-
Gilead: 'Failed' Remdesivir Solidarity Study Might Really Show Efficacy https://seekingalpha.com/article/4379587-gilead-failed-remdesivir-solidarity-study-might-really-show-efficacy
Once COVID progressed to respiratory failure requiring assisted ventilation, very likely an inflammatory phase has come into play.
Why this group was included in any analysis with the less sick patients in statistical analysis is unclear. I will attempt to exclude this group, using the limited data in the preprint, which says: ... 28-day mortality was 12% (39% if already ventilated at randomization, 10% otherwise).
Next, I am going to make the assumption, for modeling purposes, that those numbers also apply to the RDV group. If so, the above data suggest that roughly 5% of patients were on ventilators at study entry.
Using that estimate, I will next assume that the same mortality rate, 39%, that applied to the ventilated group as a whole applied to the RDV group.
That adjustment would bring the RDV mortality analysis from 10.97% to 248/2606, or 9.52%. (The denominator drops by 137, or 5% of the total RDV group; the numerator drops by 39% of 137).
This adjusted number, 9.52%, is only 85% of the 11.19% mortality rate for the placebo group. It is clinically meaningful.
So my take is that even with the many limitations of the study, the obvious study adjustment that should not have expected ventilated patients to have any benefit from RDV based on prior learnings is consistent with at least a clinically meaningful trend of RDV on mortality in COVID-19.
-
$GILD Strong earnings from Remdesivir in 2020 and 2021 will support strong rebound of #GILD back to $70s in a couple of weeks.
The worldwide shortage of Remdesivir apparently prompted many organizations like EU and WHO wanting to add chips to lower the price of Veklury in negotiating with $GILD.
Remdesivir functions effectively as nucleoside RNA polymerase inhibitor to suppress the virus reproduction. WHO Solidarity trials don’t record the timing from COVID-19 symptom to taking Remdesivir treatment! The truth is Remdesivir has to be taken as early as possible after respiratory symptoms show up. $GILD and FDA never touted Remdesivir may reduce the mortality rate but it helps patient fighting COVID-19 virus so as to REDUCE THE HOSPITALIZATION BY 4 DAYS significantly evidenced by the double blinded test result. The key is Remdesivir IS EFFECTIVE if it’s served TIMELY for COVID-19 patients within 48 hours of symptom appearance. $GILD will rebound definitely as there is no alternate to replace Remdesivir! All virus treatments need to be the cocktail approach like President Trump received and no one for now can decide “well, we throw the Remdesivir off from our COVID-19 toolbox according to WHO Solidarity trial non peer reviewed report!!!“.
“If you are a patient in the hospital with covid-19, your physician is going to want to give you remdesivir,” said Evan Seigerman, the Credit Suisse analyst who is tracking the drug’s progress and predicted up to $4.5 billion in sales in 2020 and up to $5 billion in 2021. After that, sales may decline with advent of a vaccine and possible new treatments such as monoclonal antibodies. “Remdesivir is the therapeutic of choice at the moment,” he said.
-
Perfect chance to load up #ERJ more! It’ll sky rocketing to $10s once a deal is reached with India or China! It’s on the way Dudes!
-
#BBD-B.TO won’t be let down by Canadian government! Currently the low price at 35cents is the plot of shorters of Bay Street! Don’t be fooled by Bay Street plots! The manufacturing is improving everywhere. Bombardier has the solid financial status after series of asset sell-offs. Be patient, this BBD will go back above $1 by the end of 2020!
-
Hold on guys: the exciting time is yet to come for #ERJ to get back to $10s!
-
Guys, hold #ERJ till it goes back to $10s!!!!! OR YOU’LL regret!
-
#ERJ is heading back to $10s!!!! SUPER-UNDERVALUED!
-
#ERJ Shorters apparently do not participate aftermarket trading and that’s why aftermarket trade always sees price up following the big drop of price. So fellows there, be patient! This #ERJ is worth $20 + a share!!!! It’ll soar in weeks!
DISH
DISH
SPR
GILD
GILD
GILD
ERJ
ERJ
ERJ
ERJ
ERJ
ERJ
GILD
GILD
ERJ
BBD-B.TO
ERJ
ERJ
ERJ
ERJ